Companies Represented in Panels:


Dorsey 4D Symposium hosted life sciences industry leaders, including Google Life Sciences, Samsung, GE Ventures and China Bio. Keynote speaker Governor Michael Leavitt, three-time elected governor of Utah and former Secretary of Health and Human Services under President George W. Bush, offered a new perspective on life sciences and the future of healthcare.  


Gov. Michael O. Leavitt
Keynote Speaker
Former Secretary of Health and Human Services; Founder and Chairman of Leavitt Partners
Rowan Chapman
Managing Director – New Business Creation, GE Ventures
Brian Otis
Director, Google Life Sciences
Trevor Hawkins
Senior VP - Strategy & Innovation, Siemens Healthcare Diagnostics
Kate Sharadin
Senior Director of Business Development and Strategy, Invention Science Funds – Intellectual Ventures
Paul Buckman
President & CEO, Conventus Orthopaedics
Chen Yu
Managing Partner, Vivo Capital
Jimmy Zhang
Vice President, Transactions, Johnson & Johnson Innovation
Gil Sambrano
Director of Portfolio Development & Review, California Institute for Regenerative Medicine
Greg Scott
Founder and Chairman, ChinaBio
Sofie Qiao
Venture Partner, WuXi Healthcare Ventures II and CEO of a WuXi Portfolio Company
Dr. Nick Pliam
Principal, Decheng Capital
Kevin McCormack
Communications Director, California Institute for Regenerative Medicine
Jeff Cooper
Business Development, Samsung MSCA
Neil Littman
Business Development Manager, California Institute for Regenerative Medicine
Show More

2015 Agenda

9:10 AM - 9:35 AM

Macro Trends in Healthcare – Capitalizing on Opportunities

Dr. Trevor Hawkins, Senior Vice President – Strategy & Innovation, Siemens Healthcare Diagnostics

Evan Ng, Partner, Dorsey & Whitney LLP

The world’s aging population is continuing to expand.  New processes and innovations are necessary to release the stress on the current healthcare system to support this dynamic.  Join us as Dr. Trevor Hawkins of Siemens guides us through the macro trends in healthcare and illustrates, via his expertise and experience with drugs and diagnostics, ways to capitalize on unfolding opportunities to come. 

9:35 AM - 10:05 AM

Managing Your Company through Adversity

Paul Buckman, President and Chief Executive Officer, Conventus Orthopaedics

Scott Smith, Partner, Dorsey & Whitney LLP

When Paul took over as CEO of Conventus Orthopaedics in October 2013, the company, founded in 2008, already had FDA clearance for its device but was almost completely out of money. Its original and largest investor was no longer investing in medical device startups, and no other investors were racing in to fill the void. $34 million investment dollars later, Conventus is thriving, with a new clinical direction and renewed interest from physicians. How did Paul turn around a company on the brink, in the ever-challenging world of medical devices? How do you reenergize employees and keep them excited after five, ten or even more years at a startup? In this interview with Paul, learn how he found interested investors for a company that was on the verge of closing its doors and kept employees motivated to take the company to the next level.

10:20 AM - 10:40 AM

Invention-Driven Commercialization – A Case Study

Kate Sharadin, Senior Director Business Development, Intellectual Ventures

Jennifer Spaith, Partner, Dorsey & Whitney LLP

Intellectual Ventures discusses their experience in catalyzing healthcare invention, building intellectual property portfolios, incubating start-up company opportunities and partnering for commercialization. IV’s activity in the medical technology and digital health spaces will be outlined.  Partnering opportunities with IV will be discussed, together with exciting innovative developments both upcoming and currently available.

10:40 AM - 11:15AM

Inside Google Life Sciences The Next Frontier in Healthcare

Brian Otis, Google Life Sciences

Jessica Linehan, Partner, Dorsey & Whitney LLP

Google has always had ambitions in healthcare.  The company has clearly articulated the importance of its healthcare initiatives to the market with its recent Alphabet reorganization.  Brian Otis of Google Life Sciences will demonstrate the Google Smart Contact Lens platform, and share his thoughts on the scarcity of power, extreme miniaturization, and end-to-end connected systems that span the design space from transistors to the cloud. Join us as we dig deep into one major example of Google Life Sciences’ entrees into healthcare.  

12:10 PM - 1:10 PM

Keynote Address: Governor Michael Leavitt

Former Utah Governor and Secretary of Health and Human Services; Founder and Chairman of Leavitt Partners 

1:20 PM - 2:00PM

Digital Health in the Real World – A Sneak Peek into the Future of Patient Care

Jerry Berger, Senior Manager, Healthcare | Vertical Business; Samsung Electronics America
Jeff Cooper, Business Development, Samsung MSCA

Jason Wisniewski, Partner, Dorsey & Whitney LLP

As one of the largest multinational conglomerate companies in the world, Samsung produces more than just smartphones. Their businesses span industries such as semiconductors, consumer electronics and appliances, ship building, advanced technology and medicine. During this panel and Q&A session, Samsung executives will share the company’s growing interest in healthcare and provide a sneak peek into some of their initiatives to facilitate real world use cases with health software, health service platforms on consumer devices and future hardware components for healthcare devices.

2:00 PM - 2:30 PM

California Institute for Regenerative Medicine 2.0 – Partnering Opportunities

Kevin McCormack, Senior Director Public Communications & Patient Advocate Outreach, CIRM
Neil Littmann, Business Development Manager, CIRM
Dr. Gil Sambrano, Science Officer, CIRM

David Walker, Partner, Dorsey & Whitney LLP

The California Institute for Regenerative Medicine (CIRM; also known as California's Stem Cell Agency) governs the allocation of the $3 Billion authorized to fund stem cell research in California. Panelists from CIRM will discuss the agency's history, its mission, the recent implementation of CIRM 2.0, how companies can apply for funding from CIRM and what they can do to help maximize their success.

2:50 PM - 3:30 PM

Traditional and Corporate Venture Capital – An Insider’s View

Rowan Chapman, Managing Director – New Business Creation, GE Ventures

Evan Ng, Partner, Dorsey & Whitney LLP

While traditional VCs continue to be the go-to path for startup funding, corporate VCs are increasingly gaining popularity. In this session, Rowan Chapman, who spent 11 years as a Partner at Mohr Davidow Ventures before joining GE Ventures, shares her experiences from both types of VCs. She will provide insight into how traditional and corporate VCs function, their sometimes divergent motivations, how to pitch to CVC and VCs and what entrepreneurs need to know when choosing between the two.

3:30 PM - 4:20 PM

Chinese-Financed Healthcare Investments Current Trends, Domestic and International

Greg Scott, Founder and Chairman, ChinaBio Group

Chen Yu, Managing Partner, Vivo Capital

Nick Pliam, Principal, Decheng Capital

Sofie Qiao, Venture Partner, WuXi Healthcare Ventures II & CEO, WuXi Portofolio Company

Jimmy Zhang, Vice President, Transactions, Johnson & Johnson Innovation

John Chase, Partner, Dorsey & Whitney LLP

China is consistently top of mind for entrepreneurs seeking commercial and investment opportunities. With the recent stock market and currency turmoil in China, get an up to the minute view from experienced China operatives who will share their insights on what’s hot, what’s not, and how to get things done in this tumultuous time.

4:30 PM - 5:30 PM

Networking Reception

Please reload

© 2016 Dorsey & Whitney LLP